Document ID: FDA-2022-N-0619-0002
Agency: fda
Document Type: Notice
Title: Advisory Committee; Gastrointestinal Drugs Advisory Committee; Renewal; Correction
Posted Date: 2022-05-23T04:00Z

[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Page 31245]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10941]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2022-N-0619]

Advisory Committee; Gastrointestinal Drugs Advisory Committee; 
Renewal; Correction

AGENCY: Food and Drug Administration, HHS

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
entitled ``Advisory Committee; Gastrointestinal Drugs Advisory 
Committee; Renewal'' that appeared in the Federal Register of May 11, 
2022. The document announced the renewal of the Gastrointestinal Drugs 
Advisory Committee. The document was published with the incorrect 
docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Rhea Bhatt, Division of Advisory 
Committee and Consultant Management, Center for Drug Evaluation and 
Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
31, Rm. 2434, Silver Spring, MD 20993-0002, 301-796-9001, email: 
[email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of Wednesday, May 
11, 2022 (87 FR 28834), in FR Doc. 2022-10040, on page 28834, the 
following correction is made:
    1. On page 28834, in the first column of the header of the 
document, ``Docket No. FDA-2021-N-0619'' is corrected to read ``Docket 
No. FDA-2022-N-0619''.

    Dated: May 13, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-10941 Filed 5-20-22; 8:45 am]
BILLING CODE 4164-01-P